|
|
Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) |
|
Session Chair: Dr. Kailash C. Chadha, Department of Molecular & Cellular Biology, Roswell Park Cancer Institute; Associate Research Professor, Department of Medicine State University of New York, USA
Co-Chair: Dr. Moshe Szyf, Department of Pharmacology and Therapeutics, McGill University, Canada |
|
|
Title: Inhibiting Human Prostate Cancer Metastasis by Targeting the p38 MAP Kinase-HSP27 Pathway.
Dr. Raymond Bergan, Department of Medicine, Center for Drug Discovery and Chemical Biology, Robert H. Lurie Cancer Center of Northwestern University, USA |
|
Title: Functions, Mechanisms of Action, and Regulation of Histone Deacetylases
Dr. Edward Seto, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, USA
|
|
Title: Physiological Role of Prostate-Specific Antigen (PSA): Modulator of Angiogenic Growth Factors Expression
Dr. Kailash C. Chadha, Department of Molecular & Cellular Biology, Roswell Park Cancer Institute; Associate Research Professor, Department of Medicine State University of New York, USA |
|
Title: Identification of Selective Anti-pancreatic Cancer Inhibitors Using Synthetic Lethal Chemical Screening
Dr. Xiaodong Cheng, Associate Professor, Department of Pharmacology & Toxicology, University of Texas Medical Branch, USA |
|
Title: Survival of Tumors: Investigation of Mitochondrial Function, Structure and Composition in Human Lung Cancer
Dr. Rodrigue Rossignol, French National Institute for Medical and Scientific Research and Universit¨¦ Victor Segalen Bordeaux 2, France
|
|
Title: Tumor Suppressor BARD1 Expression in Cancer: Biomarker of Cancer and Target for Treatment
Dr. Irmgard Irminger-Finger, Molecular Gynecology and Obstetrics Laboratory, Department of Gynecology and Obstetrics, University Hospitals Geneva, Switzerland
|
|
Title: Targeting Cancer by Immunotherapy: Current Challenges
Dr. R¨¦jean Lapointe, Tumour Immunology Laboratory, Montreal Cancer Institute; Department of Medicine, Universit¨¦ de Montr¨¦al, Canada |
|
Title: MBD2 a Master Regulator of Cancer Metastasis; Novel Therapeutic Opportunities
Dr. Moshe Szyf, Department of Pharmacology and Therapeutics, McGill University, Canada |
|
Title: A Novel Target for Breast and Prostate Cancer Intervention
Dr. Uri Nir, Faculty of Life Sciences, Bar-Ilan University,Israel |
|
Title: Deacetylation of cortactin by SIRT1 promotes ovarian and breast cancer cell migration
Dr. Xiaohong Zhang, MDC11, Department Pathology & Cell Biology, USF College of Medicine, USA |
|
